Document gagookdD1V4E0e5QYgBk8byVG

DownloadRandom document
Copies to: E. I. du Font de Nemours and Company Haskell Laboratory for Toxicc-logy and Industrial Medicine HASKELL LABORATORY REPORT NO. 984-77 Material Tested Haskell No. 11,336 Sample Ready for Testing 9/20/7 Other Codes Material Submitted Organic Chemicals Departm AR226-2866 ORAL LD50 TEST Procedure: The test material, as received, was administered by intragastric intubation to six grou ChR-CD male rats in single doses. Survivors were sacrificed 14 days later. The LD50 value was ca lity data using the method of D. J. Finney.t Results: Dose (mg/kg) Average Body Weight (g) Solution A- cage Dose (ml) Mortality Ratio Clinical Signs 32,530** 247 As Received 7.43 10/10 Prostration, weakness, belly-t posture, labored breathing, a matlon at 32,530 mg/kg. 20.000 241 As Received 4.46 10/10 Prostration, weakness, bellyposture, labored breathing, l chromodacryorrhea, eyes halfwet and stained perineal area loss at 20,000 mg/kg. 18,350 244 As Received 4.14 8/10 Belly-to-cage posture, prost labored breathing, salivation chromodacryorrhea, diarrha, alopecia on neck, opaque spo thalmic left eye in one rat, perineal area, stained nose, body, and weight loss at 18, 15,000 249 As Received 3.45 6/10 Prostration, weakness, belly chromodacryorrhea, wet and s area, stained mouth and nose loss at 15,000 mg/kg. r - 2 - Results: Dose .W^s) 12.500 (continued) Average Body Weight (<Q 244 11,357 238 Solution (%) Average Dose (ml) As Received 9..82 As Received 2.50 Mortality Ratio 4/10 2/10 Clinical Signs Prostration, belly-to-cage posture labored breathing, weakness, chromo cryorrhea, lacrimacion, convulsion piloerection, exophthalmos, and we loss at 12,500 ing/kg. Belly-to-cage posture, prostration weakness, chromodacryorrhea, piloe wet and stained perineal area, st mouth, nose, body, and around eyes weight loss at 11,357 ing/kg. Summary: /HIU^Mnas very low toxicity when administered orally to young adult ChR-FD male rat mg/kg ofBody weight.* * Composition: + Finney, D. J., Probit Analysis. 2nd Ed., 1952, Cambridge University Press. ** Administered as a divided dose. *** 957. Confidence Limits: Lower Upper 12,091 mg/kg 15,289 ing/kg Slope 9.38 CMH:scg Report No. 984-77 ,Date Issued: December 9, 1977 Report by: Qj/?0 L^ J /1{ Carolyn M Toxicolo Approved by: * ^.^ {/' /^^6/U^ A. Micha Chief. Oral Tox ;-i)mpany Sanftead. Does no